Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Sector movers: Electricals rise, while ex-div stocks drag pharmaceuticals lower

Wed, 15th Feb 2012 16:09

The full-year results from industrial materials maker Morgan Crucible were received well on Wednesday, helping to push the electronic and electrical equipment sector higher.Morgan Crucible saw record revenues and operating profit in 2011, with the group making rapid progress towards the attainment of the goals of its three-year plan announced a year ago. Revenue rose 8.2% to £1,101.0m in 2011 from £1,017.1m in 2010, bang in line with market expectations. Underlying profit before tax rose 58.1% to £119.7m from £75.7m in 2010, and ahead of the market consensus of £116.6m. Shares were up 9.05% at 356.6p.The company operates in the electronics market as well as petrochemical and industrial, transportation, security and defence and healthcare sectors. In electronics, the firm's applications range from energy harvesting to semiconductor manufacturing and consumer electronics.Sector peers Elektron Technology, TT electronics and RCG Holdings were also making decent gains today.Meanwhile, the pharmaceuticals and biotechnology sector was the worst performing sector today with its two largest constituents AstraZeneca and GlaxoSmithKline registering losses on the FTSE 100 after going ex-dividend. BCTop performing sectors so far todayElectronic & Electrical Equipment 3,300.10 +2.19%Personal Goods 22,423.89 +2.02%Banks 4,019.08 +1.98%Industrial Engineering 7,678.52 +1.64%Software & Computer Services 799.79 +1.11%Bottom performing sectors so far todayPharmaceuticals & Biotechnology 9,830.87 -2.04%Food Producers & Processors 5,500.23 -0.86%Mining 22,344.54 -0.81%Oil & Gas Producers 8,800.29 -0.81%Real Estate Investment Trusts 1,896.80 -0.44%

Related Shares

More News
Today 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

Today 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.